National Post Health Canada approves first drug specifically made to treat moderate to severe postpartum depression
ZURZUVAE, also known as zuranoline, is a 14-day treatment but clinical trials have reported to show improvements as early as day three
ZURZUVAE, also known as zuranoline, is a 14-day treatment but clinical trials have reported to show improvements as early as day three